Ionis Pharmaceuticals (IONS) Long-Term Investments (2010 - 2012)

Ionis Pharmaceuticals' Long-Term Investments history runs 3 years deep, the most recent figure standing at -$5.6 million for Q3 2012.

• On a quarterly basis, Long-Term Investments fell 76.88% year-over-year to -$5.6 million in Q3 2012; TTM through Sep 2012 was -$5.6 million, a 76.88% decrease from a year earlier, with the FY2011 full-year figure at -$4.4 million, down 408.51% from the prior year.
• Long-Term Investments held at -$5.6 million in Q3 2012 per IONS's latest filing, from -$5.6 million in the prior quarter.
• Across five years, Long-Term Investments topped out at -$870000.0 in Q4 2010 and bottomed at -$5.6 million in Q2 2012.
• The 3-year median for Long-Term Investments is -$4.2 million (2010), against an average of -$3.9 million.
• Biggest YoY gain for Long-Term Investments was 37.1% in 2011; the steepest drop was 408.51% in 2011.
• Year by year, Long-Term Investments stood at -$870000.0 in 2010, then plunged by 408.51% to -$4.4 million in 2011, then fell by 25.75% to -$5.6 million in 2012.
• Per Business Quant, the three latest IONS Long-Term Investments figures stand at -$5.6 million (Q3 2012), -$5.6 million (Q2 2012), and -$5.4 million (Q1 2012).